WDNAETF / FundWisdomTree BioRevolution Fund
Verdicts genuinely change. Free email alert the moment WDNA's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
WisdomTree BioRevolution Fund ETF · WisdomTree Trust
81 holdings · as of 2026-06-30 (4.5 months ago) The fund may have traded since. SEC Form N-PORT is filed quarterly and lags the period it covers, so these are the most recent holdings on file, not the fund’s holdings today.
NON-COMPLIANT 39.16% of portfolio weight is in non-compliant holdings, over the 5% threshold.
81 holdings, 64 matched (84% of weight). Portfolio as of 2026-06-30, filed 2026-08-31. Source: SEC Form N-PORT.
6.69% of this portfolio’s income is non-permissible — weighted across holdings, computed over 71% of portfolio weight (53 of 81 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
44.8% compliant 0.0% questionable 39.2% non-compliant 16.0% unscreened
All holdings (81)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| TWST TWIST BIOSCIENCE CORP | COMPLIANT | 5.95% | AAOIFI1.1% Usmani13.9% Dow Jones Islamic3.2% S&P Shariah3.5% MSCI Islamic13.9% MSCI Islamic M-Series3.5% FTSE Shariah0.0% |
| MRNA MODERNA INC | NON_COMPLIANT | 4.14% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| LLY ELI LILLY & COMPANY | COMPLIANT | 4.08% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| JNJ JOHNSON & JOHNSON | COMPLIANT | 2.97% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| UTHR UNITED THERAPEUTICS CORP | NON_COMPLIANT | 2.45% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| NTRA NATERA INC | COMPLIANT | 2.32% | AAOIFI0.5% Usmani9.0% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic9.0% MSCI Islamic M-Series1.2% FTSE Shariah3.0% |
| TEM TEMPUS AI INC | COMPLIANT | 2.28% | AAOIFI0.7% Usmani3.5% Dow Jones Islamic0.8% S&P Shariahpass MSCI Islamic3.5% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| IMNM IMMUNOME INC | NON_COMPLIANT | 2.26% | AAOIFI0.2% Usmani0.8% Dow Jones Islamic0.3% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| GPCR STRUCTURE THERAPEUTICS INC | NON_COMPLIANT | 2.11% | AAOIFI0.2% Usmani0.4% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.4% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| STOK STOKE THERAPEUTICS INC | NON_COMPLIANT | 2.09% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| BEAM BEAM THERAPEUTICS INC | NON_COMPLIANT | 2.09% | AAOIFI8.2% Usmani17.8% Dow Jones Islamic10.4% S&P Shariah10.7% MSCI Islamic17.8% MSCI Islamic M-Series10.7% FTSE Shariah7.2% |
| CTVA CORTEVA INC | COMPLIANT | 1.99% | AAOIFI55.0% Usmani8.0% Dow Jones Islamic7.3% S&P Shariah7.9% MSCI Islamic8.0% MSCI Islamic M-Series7.9% FTSE Shariah8.0% |
| KRYS KRYSTAL BIOTECH INC | NON_COMPLIANT | 1.96% | AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| DAR DARLING INGREDIENTS INC | NON_COMPLIANT | 1.94% | AAOIFI42.8% Usmani34.7% Dow Jones Islamic52.9% S&P Shariah54.0% MSCI Islamic34.7% MSCI Islamic M-Series54.0% FTSE Shariah32.6% |
| IONS IONIS PHARMACEUTICALS INC | NON_COMPLIANT | 1.86% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
| AZN ASTRAZENECA PLC | COMPLIANT | 1.83% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| TXG 10X GENOMICS INC | COMPLIANT | 1.81% | AAOIFI1.0% Usmani7.6% Dow Jones Islamic3.2% S&P Shariah2.5% MSCI Islamic7.6% MSCI Islamic M-Series2.5% FTSE Shariah0.0% |
| CRSP CRISPR THERAPEUTICS AG | NON_COMPLIANT | 1.77% | AAOIFI15.5% Usmani29.6% Dow Jones Islamic17.0% S&P Shariah16.8% MSCI Islamic29.6% MSCI Islamic M-Series16.8% FTSE Shariah22.1% |
| ROIVANT SCIENCES LTD | UNSCREENED | 1.73% | no in-house ratios for this holding |
| ABSI ABSCI CORP | COMPLIANT | 1.71% | AAOIFIpass Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| REVOLUTION MEDICINES INC | UNSCREENED | 1.69% | no in-house ratios for this holding |
| AGIO AGIOS PHARMACEUTICALS INC | NON_COMPLIANT | 1.57% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| AMGN AMGEN INC | COMPLIANT | 1.54% | AAOIFI24.9% Usmani59.9% Dow Jones Islamic33.6% S&P Shariah35.1% MSCI Islamic59.9% MSCI Islamic M-Series35.1% FTSE Shariah59.9% |
| BAYN.DE BAYER AG | NON_COMPLIANT | 1.53% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| TMO THERMO FISHER SCIENTIFIC INC | COMPLIANT | 1.52% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| GILD GILEAD SCIENCES INC | COMPLIANT | 1.51% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| BG BUNGE GLOBAL SA | NON_COMPLIANT | 1.51% | AAOIFI81.7% Usmani34.4% Dow Jones Islamic97.8% S&P Shariah104.4% MSCI Islamic34.0% MSCI Islamic M-Series104.4% FTSE Shariah30.6% |
| ARWR ARROWHEAD PHARMACEUTICALS INC | COMPLIANT | 1.47% | AAOIFI11.9% Usmani46.3% Dow Jones Islamic12.9% S&P Shariah15.5% MSCI Islamic46.3% MSCI Islamic M-Series15.5% FTSE Shariah39.3% |
| VCYT VERACYTE INC | COMPLIANT | 1.46% | AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0% |
| BIOHAVEN LTD | UNSCREENED | 1.37% | no in-house ratios for this holding |
| NOVONESIS A/S | UNSCREENED | 1.37% | no in-house ratios for this holding |
| PFE PFIZER INC | NON_COMPLIANT | 1.34% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| VRTX VERTEX PHARMACEUTICALS INC | COMPLIANT | 1.34% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| NVS NOVARTIS AG | COMPLIANT | 1.33% | AAOIFI12.5% Usmani25.9% Dow Jones Islamic11.8% S&P Shariah12.6% MSCI Islamic25.9% MSCI Islamic M-Series12.6% FTSE Shariah25.9% |
| UNIQURE NV | UNSCREENED | 1.23% | no in-house ratios for this holding |
| CATALYST PHARMACEUTICALS INC | UNSCREENED | 1.07% | no in-house ratios for this holding |
| EXEL EXELIXIS INC | COMPLIANT | 1.04% | AAOIFI1.2% Usmani6.7% Dow Jones Islamic1.5% S&P Shariah1.7% MSCI Islamic6.7% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| CGEM CULLINAN THERAPEUTICS INC | NON_COMPLIANT | 1.04% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| PTGX PROTAGONIST THERAPEUTICS INC | NON_COMPLIANT | 1.03% | AAOIFI0.1% Usmani1.0% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic1.0% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| DYNE THERAPEUTICS INC | UNSCREENED | 1.00% | no in-house ratios for this holding |
| CELLDEX THERAPEUTICS INC | UNSCREENED | 0.96% | no in-house ratios for this holding |
| EDIT EDITAS MEDICINE INC | NON_COMPLIANT | 0.95% | AAOIFI21.1% Usmani32.3% Dow Jones Islamic29.0% S&P Shariah21.1% MSCI Islamic32.3% MSCI Islamic M-Series21.1% FTSE Shariah25.9% |
| ARGX ARGENX SE | COMPLIANT | 0.94% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| VIKING THERAPEUTICS INC | UNSCREENED | 0.93% | no in-house ratios for this holding |
| RGNX REGENXBIO INC | NON_COMPLIANT | 0.93% | AAOIFI11.7% Usmani17.8% Dow Jones Islamic14.0% S&P Shariah12.0% MSCI Islamic17.8% MSCI Islamic M-Series12.0% FTSE Shariah0.0% |
| CG ONCOLOGY INC | UNSCREENED | 0.90% | no in-house ratios for this holding |
| 22UA.DE BIONTECH SE | NON_COMPLIANT | 0.88% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| BIIB BIOGEN INC | COMPLIANT | 0.82% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| ALLOGENE THERAPEUTICS INC | UNSCREENED | 0.82% | no in-house ratios for this holding |
| IOVA IOVANCE BIOTHERAPEUTICS INC | COMPLIANT | 0.77% | AAOIFI1.2% Usmani5.0% Dow Jones Islamic2.9% S&P Shariah2.4% MSCI Islamic5.0% MSCI Islamic M-Series2.4% FTSE Shariah0.0% |
| DHR DANAHER CORP | COMPLIANT | 0.75% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| RGEN REPLIGEN CORP | COMPLIANT | 0.72% | AAOIFI7.3% Usmani23.4% Dow Jones Islamic8.8% S&P Shariah8.4% MSCI Islamic23.4% MSCI Islamic M-Series8.4% FTSE Shariah18.7% |
| MRK MERCK & COMPANY INC | COMPLIANT | 0.70% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| SANA BIOTECHNOLOGY INC | UNSCREENED | 0.67% | no in-house ratios for this holding |
| VERBIO VEREINIGTE BIOENERGIE SE | UNSCREENED | 0.66% | no in-house ratios for this holding |
| HALO HALOZYME THERAPEUTICS INC | COMPLIANT | 0.65% | AAOIFI17.2% Usmani83.3% Dow Jones Islamic27.4% S&P Shariah30.4% MSCI Islamic83.3% MSCI Islamic M-Series30.4% FTSE Shariah83.3% |
| RARE ULTRAGENYX PHARMACEUTICAL INC | NON_COMPLIANT | 0.60% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| SYENS.BR SYENSQO SA/NV | NON_COMPLIANT | 0.59% | AAOIFIfail Usmanipass Dow Jones Islamicfail S&P Shariahfail MSCI Islamicpass MSCI Islamic M-Seriesfail FTSE Shariahpass |
| FMC FMC CORP | NON_COMPLIANT | 0.58% | AAOIFI271.1% Usmani48.1% Dow Jones Islamic115.5% S&P Shariah91.6% MSCI Islamic48.1% MSCI Islamic M-Series91.6% FTSE Shariah46.8% |
| INSMED INC | UNSCREENED | 0.58% | no in-house ratios for this holding |
| GPRE GREEN PLAINS INC | NON_COMPLIANT | 0.58% | AAOIFI48.2% Usmani31.5% Dow Jones Islamic71.1% S&P Shariah55.2% MSCI Islamic31.5% MSCI Islamic M-Series55.2% FTSE Shariah27.6% |
| ARCTURUS THERAPEUTICS HOLDINGS INC | UNSCREENED | 0.55% | no in-house ratios for this holding |
| ILMN ILLUMINA INC | COMPLIANT | 0.54% | AAOIFI1.6% Usmani8.1% Dow Jones Islamic2.7% S&P Shariah2.7% MSCI Islamic8.1% MSCI Islamic M-Series2.7% FTSE Shariah0.0% |
| REGN REGENERON PHARMACEUTICALS INC | COMPLIANT | 0.54% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| NTLA INTELLIA THERAPEUTICS INC | NON_COMPLIANT | 0.53% | AAOIFI4.1% Usmani8.6% Dow Jones Islamic5.1% S&P Shariah4.1% MSCI Islamic8.6% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| NUF.AX NUFARM LTD | NON_COMPLIANT | 0.50% | AAOIFIfail Usmanipass Dow Jones Islamicfail S&P Shariahfail MSCI Islamicpass MSCI Islamic M-Seriesfail FTSE Shariahpass |
| TECH BIO-TECHNE CORP | COMPLIANT | 0.49% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| BBIO BRIDGEBIO PHARMA INC | COMPLIANT | 0.48% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BMRN BIOMARIN PHARMACEUTICAL INC | NON_COMPLIANT | 0.44% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GMAB.CO GENMAB A/S | COMPLIANT | 0.42% | AAOIFIpass Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| ONT.L OXFORD NANOPORE TECHNOLOGIES PLC | NON_COMPLIANT | 0.40% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| ZTS ZOETIS INC | NON_COMPLIANT | 0.36% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| GNS.L GENUS PLC | COMPLIANT | 0.34% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| GERON CORP | UNSCREENED | 0.33% | no in-house ratios for this holding |
| TSN TYSON FOODS INC | NON_COMPLIANT | 0.30% | AAOIFI45.2% Usmani22.5% Dow Jones Islamic40.2% S&P Shariah41.7% MSCI Islamic22.5% MSCI Islamic M-Series41.7% FTSE Shariah22.5% |
| RCKT ROCKET PHARMACEUTICALS INC | NON_COMPLIANT | 0.30% | AAOIFI0.8% Usmani5.9% Dow Jones Islamic0.5% S&P Shariah0.3% MSCI Islamic0.8% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| ALNY ALNYLAM PHARMACEUTICALS INC | COMPLIANT | 0.29% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| SRPT SAREPTA THERAPEUTICS INC | NON_COMPLIANT | 0.28% | AAOIFI43.1% Usmani32.8% Dow Jones Islamic21.4% S&P Shariah14.9% MSCI Islamic32.8% MSCI Islamic M-Series14.9% FTSE Shariah26.6% |
| PACB PACIFIC BIOSCIENCES OF CALIFORNIA INC | NON_COMPLIANT | 0.26% | AAOIFI168.3% Usmani93.9% Dow Jones Islamic143.6% S&P Shariah79.6% MSCI Islamic93.9% MSCI Islamic M-Series79.6% FTSE Shariah85.7% |
| QGEN QIAGEN NV | COMPLIANT | 0.25% | AAOIFI20.8% Usmani28.9% Dow Jones Islamic18.9% S&P Shariah18.9% MSCI Islamic28.9% MSCI Islamic M-Series18.9% FTSE Shariah26.3% |
| DREYFUS TRSY OBLIG CASH M | UNSCREENED | 0.11% | no in-house ratios for this holding |
The published standards disagree about this fund by 29 points of portfolio weight — 40.4% of it passes AAOIFI, 11.5% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 40.4% ratios fail on 37.3% 22.3% not rated under AAOIFI
ratios pass on 25.0% ratios fail on 53.0% 22.0% not rated under Usmani
ratios pass on 37.7% ratios fail on 36.8% 25.5% not rated under Dow Jones Islamic
ratios pass on 38.1% ratios fail on 33.4% 28.5% not rated under S&P Shariah
ratios pass on 11.5% ratios fail on 66.2% 22.3% not rated under MSCI Islamic
ratios pass on 38.1% ratios fail on 36.1% 25.7% not rated under MSCI Islamic M-Series
ratios pass on 26.3% ratios fail on 50.4% 23.3% not rated under FTSE Shariah
64 of 81 listed holdings carry our own per-methodology verdicts (84% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 49 (71% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| MRNA MODERNA INC | 4.14% |
| UTHR UNITED THERAPEUTICS CORP | 2.45% |
| IMNM IMMUNOME INC | 2.26% |
| GPCR STRUCTURE THERAPEUTICS INC | 2.11% |
| STOK STOKE THERAPEUTICS INC | 2.09% |
| BEAM BEAM THERAPEUTICS INC | 2.09% |
| KRYS KRYSTAL BIOTECH INC | 1.96% |
| DAR DARLING INGREDIENTS INC | 1.94% |
| IONS IONIS PHARMACEUTICALS INC | 1.86% |
| CRSP CRISPR THERAPEUTICS AG | 1.77% |
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
WisdomTree BioRevolution Fund (WDNA) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for WDNA — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 43.40 | NEUTRAL |
| Stochastic %K (14) | 1.13 | BUY |
| CCI (20) | -126.12 | BUY |
| Williams %R (14) | -98.87 | BUY |
| MACD (12,26,9) | -0.13 | SELL |
| ROC (10) | -6.37 | SELL |
| Momentum (10) | -1.53 | SELL |
| EMA (10) | 23.29 | SELL |
| SMA (10) | 23.40 | SELL |
| EMA (20) | 23.39 | SELL |
| SMA (20) | 23.51 | SELL |
| EMA (30) | 23.35 | SELL |
| SMA (30) | 23.35 | SELL |
| EMA (50) | 23.09 | SELL |
| SMA (50) | 23.29 | SELL |
| EMA (100) | 22.16 | BUY |
| SMA (100) | 22.23 | BUY |
| EMA (200) | 20.40 | BUY |
| SMA (200) | 20.04 | BUY |
About WisdomTree BioRevolution Fund
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 44 |
| ⏱ 15-Min | BEARISH | 31 |
| ⏲ 5-Min | BEARISH | 94 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-03 · Asset managers net 928584 (+5135)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.